In this chapter, I reconceptualize elements of the “placebo effect” as the meaning response. The meaning response is defined as the physiological or psychological effects of meaning in the treatment of illness. Much of what is called the placebo effect – meaning responses elicited with inert medications – is a special case of the meaning response, as is the “nocebo effect”. Several implications...

Background: This study aimed to evaluate whether the high frequency of reported statin adverse effects (AEs) may be associated with nocebo effect. We compared nocebo-related subjective AEs objective and investigated factors potentially Methods: A retrospective cohort was conducted using Food Drug Administration Adverse Event Reporting System between January 2010 December 2019 for statins, inclu...

To describe the role of internet and cognitive biases in controversy surrounding chronic Lyme disease. The attribution but aspecific symptoms to borreliosis is a source worldwide controversy. Some patients attribute their even though, fact, they have functional somatic syndrome. These patients’ diagnostic therapeutic wandering contributes above suffering. Internet has deregulated information ma...

It is well-known that placebo is a substance without medical effects, which benefits the health status because of the patient's belief that the substance is effective and that the nocebo is defined as a substance without medical effects but which worsenes the health status of the person taking it by the negative beliefs and expectations of the patient. Starting with the history of the placebo e...

Background Placebo-controlled oral drug provocation tests (DPTs) are an important step in drug hypersensitivity diagnosis. Administration of placebo (an inert sostance not detectable from drug) is recommended to avoid psychological influences on the interpretation of DPT results, however actually little is known about how to deal a reaction to placebo and how to go further with the diagnostic p...

The paper updates the word ”psychogenic”; suggests a pathophysiologic reading of the psychogenic contribute to CPP, via the stress-induced corticotropin-releasing factor (CRF) signaling pathways, and differentiates predisposing, precipitating and maintaining factors; summarizes the pertinent evidence; focuses on the differential diagnosis between prominent “psychogenic” vs somatic etiology of C...

INTRODUCTION Patients require an accurate knowledge about placebos and their possible effects to ensure consent for placebo-controlled clinical trials is adequately informed. However, few previous studies have explored patients' baseline (ie, pretrial recruitment) levels of understanding and knowledge about placebos. The present online survey aimed to assess knowledge about placebos among patie...